TY  - GEN
AU  - Denis,Kevin
AU  - Le Bris,Marion
AU  - Le Guennec,Loic
AU  - Barnier,Jean-Philippe
AU  - Faure,Camille
AU  - Gouge,Anne
AU  - Bouzinba-Ségard,Haniaa
AU  - Jamet,Anne
AU  - Euphrasie,Daniel
AU  - Durel,Beatrice
AU  - Barois,Nicolas
AU  - Pelissier,Philippe
AU  - Morand,Philippe C
AU  - Coureuil,Mathieu
AU  - Lafont,Frank
AU  - Join-Lambert,Olivier
AU  - Nassif,Xavier
AU  - Bourdoulous,Sandrine
TI  - Targeting Type IV pili as an antivirulence strategy against invasive meningococcal disease
SN  - 2058-5276
PY  - 2019///0725
KW  - Animals
KW  - Anti-Bacterial Agents
KW  - pharmacology
KW  - Blood Vessels
KW  - injuries
KW  - Drug Combinations
KW  - Electron Transport Complex I
KW  - Female
KW  - Fimbriae, Bacterial
KW  - drug effects
KW  - Gene Expression Profiling
KW  - Gene Expression Regulation, Bacterial
KW  - Gram-Negative Bacteria
KW  - Humans
KW  - Meningococcal Infections
KW  - prevention & control
KW  - Mice
KW  - Neisseria meningitidis
KW  - Phenothiazines
KW  - Skin
KW  - pathology
KW  - Skin Transplantation
KW  - Sodium-Potassium-Exchanging ATPase
KW  - Trifluoperazine
KW  - Virulence Factors
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/s41564-019-0395-8
ER  -